Silo Pharma, Inc. (SILO)
2.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
2.15
0.00 (0.00%)
After-Hours: 20:00
Silo Pharma Net Income (Quarterly) : -0.8328M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8328M |
| March 31, 2026 | -1.647M |
| December 31, 2025 | -0.8815M |
| September 30, 2025 | -1.110M |
| June 30, 2025 | -1.204M |
| March 31, 2025 | -1.031M |
| December 31, 2024 | -1.731M |
| September 30, 2024 | -0.9288M |
| June 30, 2024 | -0.9318M |
| March 31, 2024 | -0.8017M |
| December 31, 2023 | -1.052M |
| September 30, 2023 | -0.6602M |
| June 30, 2023 | -1.013M |
| March 31, 2023 | -0.9064M |
| December 31, 2022 | -1.663M |
| September 30, 2022 | -0.9832M |
| June 30, 2022 | -0.6584M |
| March 31, 2022 | -0.6029M |
| December 31, 2021 | -1.063M |
| September 30, 2021 | 6.472M |
| June 30, 2021 | -0.462M |
| March 31, 2021 | -0.8637M |
| December 31, 2020 | -0.6007M |
| September 30, 2020 | -0.5565M |
| June 30, 2020 | -1.375M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2389M |
| December 31, 2019 | -0.3821M |
| September 30, 2019 | -0.2655M |
| June 30, 2019 | -0.2422M |
| March 31, 2019 | -0.1235M |
| September 30, 2018 | -0.1982M |
| June 30, 2018 | -0.3159M |
| March 31, 2018 | 0.0175M |
| December 31, 2017 | 0.2069M |
| September 30, 2017 | -0.5191M |
| June 30, 2017 | -0.076M |
| March 31, 2017 | 0.7448M |
| December 31, 2016 | -0.143M |
| September 30, 2016 | -0.4315M |
| June 30, 2016 | -0.4343M |
| March 31, 2016 | -0.1041M |
| December 31, 2015 | 0.0068M |
| September 30, 2015 | -0.4608M |
| June 30, 2015 | 0.0161M |
| March 31, 2015 | 0.0285M |
| December 31, 2014 | -0.0466M |
| September 30, 2014 | -0.3353M |
| June 30, 2014 | -0.43M |
| March 31, 2014 | 0.4356M |
| December 31, 2013 | 0.084M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.8328M |
| EPS Diluted (Quarterly) | -0.7581 |
| Enterprise Value | -3.006M |
| Earnings Yield | -248.3% |
| Normalized Earnings Yield | -243.10 |